ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kesecioglu, J.
Right arrow Articles by Lachmann, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kesecioglu, J.
Right arrow Articles by Lachmann, B.
Eur Respir J 2002; 19:820-826
Copyright ©ERS Journals Ltd 2002


Iodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome

J. Kesecioglu1, M.J. Schultz2, J.J. Haitsma3, G.J. den Heeten4 and B. Lachmann3

1 Dept of Anaesthesiology, Cardiothoracic and Neurosurgical Intensive Care Unit, University Medical Centre Utrecht, 2 Dept of Intensive Care, Academic Medical Centre, University of Amsterdam, 3 Dept of Anaesthesiology, Erasmus University Rotterdam and 4 Dept of Radiology, Academic Medical Centre, University of Amsterdam, the Netherlands

CORRESPONDENCE: J. Kesecioglu, Dept of Anesthesiology, Cardiothoracic and Neurosurgical Intensive Care Unit, Division of Perioperative Medicine and Emergency Care, University Medial Center Utrecht, Mail Stop, E03-511, P.O. Box 85500, 3508 GA Utrecht, The Netherlands. Fax: 31 302541828. E-mail: j.kesecioglu@azu.nl

Keywords: exogenous surfactant, iodixanol, lung lavage, oxygenation, respiratory distress, surface tension

Received: July 3, 2001
Accepted December 12, 2001

Optimal alveolar distribution of exogenous surfactant is an important determinant of its beneficial effect. This distribution can be determined by suspending surfactant in a radiological contrast medium before intratracheal instillation, followed by radiological imaging. Iodixanol is reported to be a safe contrast medium that causes no lung injury when instilled intratracheally.

In this study, the effects of surfactant suspended in saline were compared with surfactant suspended either in 4:1 saline-iodixanol (64 mg iodine·mL–1) or in 1:1 saline-iodixanol (160 mg iodine·mL–1), on oxygenation and lung mechanics in a rat model of adult respiratory distress syndrome (ARDS) induced by lung lavage.

After the induction of ARDS, surfactant instillation improved oxygenation, total lung volume at inflation with a distending pressure of 35 cmH2O, lung volume at transpulmonary pressure of 5 cmH2O and Gruenwald index. The effects of surfactant suspended in 4:1 saline-iodixanol were similar to those of surfactant alone. However, instillation of surfactant suspended in 1:1 saline-iodixanol resulted in significantly lower values in all measured parameters. Surface tension was the lowest in surfactant suspended in saline alone and addition of iodixanol led to an increase in surface tension in a dose-dependent manner.

In conclusion, iodixanol at the higher dose caused an inhibition of the exogenous surfactant effect, characterized as a lack of improvement in oxygen tension in arterial blood, low total lung compliance, volume at 5 cmH2O end-expiration and Gruenwald index. This effect of iodixanol was probably due to its high surface tension, especially if a high concentration was used. Surfactant suspended in a lower concentration of iodixanol seems a better alternative, allowing for radiological imaging of the distribution of surfactant when intratracheally instilled.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.